The table below shows TG THERAPEUTICS, INC.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
-$17.89M
-$28.71M
-$8.21M
-$59.90M
-$68.69M
-$81.36M
Capital expenditure
$51.00K
$25.00K
$0.00
-
$7.00K
$67.00K
Investing cash flow
-$9.86M
-$12.93M
-$9.26M
-$6.17M
-$43.67M
-$514.00K
Dividends paid
-
-
-
TGTX operating cash flow (10-K history)
TG THERAPEUTICS, INC. reported operating cash flow of -$24.77M for fiscal year 2025. That is up 38.9% from -$40.52M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$5.19M (FY 2012) to -$24.77M. Figures come from the company's audited annual reports as filed with the SEC.
